Records containing: Recurrent Pancreatic Cancer

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2025-08-01
Diagnostic Efficacy of 18F-FAPI-74 PET/CT in Patients With Pancreatic Cancer
CLINICAL_TRIALS study record update · 2025-01-13
Neoadjuvant FOLFIRINOX and Chemoradiation Followed by Definitive Surgery and Postoperative Gemcitabine for Patients with Borderline Resectable Pancreatic Adenocarcinoma: an Intergroup Single-Arm Pilot Study
CLINICAL_TRIALS study record update · 2024-03-04
Phase I Pilot Study of Vaccine Therapy With Tumor-Specific Mutated Ras Peptides in the Adjuvant Setting in Patients With Colorectal, Pancreatic, or Lung Cancer
CLINICAL_TRIALS study record update · 2023-09-01
Prospective Exploratory Study of Tislelizumab Combined With Nab-paclitaxel and Gemcitabine for Postoperative Recurrence of Pancreatic Cancer
CLINICAL_TRIALS study record update · 2023-07-12
A Phase I Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer and Good Performance Status
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2022-09-13
A Phase I/II Study of Sorafenib and Everolimus in Patients With Advanced Solid Tumors and Gemcitabine-Refractory Metastatic Pancreatic Cancer
CLINICAL_TRIALS study record update · 2022-08-02
Phase I Study of the Combination of MLN8237 and Gemcitabine in Advanced Solid Tumors With Emphasis on Pancreatic Cancer
CLINICAL_TRIALS study record update · 2021-08-10
A Phase II Study of Metformin Plus Modified FOLFOX 6 in Patients With Metastatic Pancreatic Cancer
CLINICAL_TRIALS study record update · 2020-12-30
A Phase 2 Study of Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2020-06-26
A Pilot Trial of Stereotactic Body Radiation Therapy and Metformin for Borderline-Resectable and Locally-Advanced Pancreatic Adenocarcinomas
CLINICAL_TRIALS study record update · 2020-03-06
Ipilimumab and Gemcitabine for Advanced Pancreas Cancer: A Phase Ib Study
CLINICAL_TRIALS study record update · 2020-01-23
A Randomized Trial of a Family Caregiver Palliative Care Intervention
CLINICAL_TRIALS study record update · 2019-09-06
Phase 1-2 18F-FPPRGD2 PET/CT or PET/MRI Imaging of αvβ3 Integrins Expression as a Biomarker of Angiogenesis
CLINICAL_TRIALS study record update · 2019-04-08
Phase I Trial of The Combination of Vismodegib and Sirolimus
CLINICAL_TRIALS study record update · 2018-12-27
A Pilot Study: Open-Label Clinical Trial of CPI-613 in Patients With Metastatic Pancreatic Adenocarcinoma and Poor Performance Status
CLINICAL_TRIALS study record update · 2018-07-03
A Phase 1, Open-Label, Dose-Ranging Study to Assess the Safety and Immunologic Activity of APN401
CLINICAL_TRIALS study record update · 2018-01-09
A Multicenter, Open-Label, Randomized, Phase II Trial of Adjuvant Dasatinib Plus Gemcitabine Versus Single-Agent Gemcitabine in Patients With Resected Pancreatic Adenocarcinoma
CLINICAL_TRIALS study record update · 2017-08-01
A Phase I Study of an MVA Vaccine Targeting P53 in Cancer
CLINICAL_TRIALS study record update · 2016-12-09
A Phase II Study of the Halichondrin B Analog E7389 as Second Line Therapy for Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
CLINICAL_TRIALS study record update · 2016-11-07
A Phase 2 Study of AZD6244 Plus Erlotinib for the Second-Line Treatment of Advanced Pancreatic Adenocarcinoma
CLINICAL_TRIALS study record update · 2015-09-30
A Phase I Clinical and Biological Evaluation of Combined EGFR Blockade With Erlotinib and Cetuximab in Patients With Advanced Cancer
CLINICAL_TRIALS study record update · 2015-04-28
Phase II Randomized Study of Surgical Resection and Adjuvant Gemcitabine Hydrochloride With Versus Without Bevacizumab in Patients With Adenocarcinoma of the Pancreas
CLINICAL_TRIALS study record update · 2015-04-21
A Phase II Study of Sequential Paclitaxel and Bryostatin-1 for Patients With Advanced Pancreatic Cancer
CLINICAL_TRIALS study record update · 2015-01-09
A Phase Ib Study of Dovitinib in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced Solid Tumors and Pancreatic Cancer
CLINICAL_TRIALS study record update · 2014-12-23
Integration of Palliative Care Planning in Pancreatic and Ovarian Cancers